8-K
XBRL
8-K
- Company
- ROCKET PHARMACEUTICALS, INC.
- Filed
- July 17, 2025
- Period of Report
- July 17, 2025
- Accession Number
- 0001140361-25-026132
An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →